Follow the people · Insider
Jack W. Schuler
Jack W. Schuler files insider transactions with the SEC as a 10% owner and other role of Biodesix (BDSX). We hold 7 disclosed purchases and sales filed since 30 January 2006, 3 of them in the last 90 days.
- Files forBDSX
- Disclosed buys and sells7 in all, 3 in the last 90 days
- Last disclosure13 August 2026
Positions held
20 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 22 June 2020 — 12 August 202610% owner and Other role · Biodesix (BDSX)76 Form 4 lines · source: SEC Form 4
- Filed 17 September 2025 — 5 June 202610% owner · Aspira Women's Health (AWHL)4 Form 4 lines · source: SEC Form 4
- Filed 1 July 2020 — 6 March 202510% owner · Aspira Women's Health (AWH)9 Form 4 lines · source: SEC Form 4
- Filed 6 March 2013 — 3 December 2024Director and 10% owner · Accelerate Diagnostics (AXDX)225 Form 4 lines · source: SEC Form 4
- Filed 3 July 2017 — 20 December 202310% owner · Yield10 Bioscience (YTEN)67 Form 4 lines · source: SEC Form 4
- Filed 21 December 2018 — 9 December 202210% owner · Soleno Therapeutics (SLNO)118 Form 4 lines · source: SEC Form 4
- Filed 19 December 2013 — 9 June 202010% owner · Vermillion (VRML)27 Form 4 lines · source: SEC Form 4
- Filed 3 February 2006 — 14 May 2020Director and 10% owner · Quidel Corp /de/ (QDEL)291 Form 4 lines · source: SEC Form 4
- Filed 1 October 2015 — 11 February 202010% owner · Biolase (BIOL)41 Form 4 lines · source: SEC Form 4
- Filed 3 May 2006 — 30 April 2018Chairman · Stericycle (SRCL)115 Form 4 lines · source: SEC Form 4
- Filed 28 October 2013 — 1 April 2017Director and 10% owner · Accelerate Diagnostics (AXDX])12 Form 4 lines · source: SEC Form 4
- Filed 28 July 2015 — 28 July 201510% owner · Neos Therapeutics (NEOS)17 Form 4 lines · source: SEC Form 4
- Filed 19 June 2015 — 19 June 201510% owner · Metabolix (MBLX)2 Form 4 lines · source: SEC Form 4
- Filed 8 August 2013 — 15 June 2015Director and 10% owner · Hansen Medical (HNSN)5 Form 4 lines · source: SEC Form 4
- Filed 2 November 2009 — 21 March 201410% owner · Gtx Inc /de/ (GTXI)55 Form 4 lines · source: SEC Form 4
- Filed 27 January 2006 — 10 May 2013Director · Medtronic (MDT)170 Form 4 lines · source: SEC Form 4
- Filed 26 June 2012 — 26 June 2012Director and 10% owner · Accelr8 Technology (AXK)3 Form 4 lines · source: SEC Form 4
- Filed 22 November 2011 — 22 November 201110% owner · Transition Therapeutics (TTHI)1 Form 4 line · source: SEC Form 4
- Filed 22 May 2007 — 19 February 2008Director · Ventana Medical Systems (VMSI)44 Form 4 lines · source: SEC Form 4
- Filed 8 March 2007 — 8 March 2007Director · Medtronic (mdt)4 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- ▲ bought on the open market 15,000 shares of BiodesixSEC Form 413 August 2026Common Stock · traded 12 August 2026 · filed 13 August 2026
- ▲ bought on the open market 13,900 shares of BiodesixSEC Form 412 August 2026Common Stock · traded 10 August 2026 · filed 12 August 2026
- ▲ bought on the open market 13,700 shares of BiodesixSEC Form 412 August 2026Common Stock · traded 11 August 2026 · filed 12 August 2026
- ▲ bought on the open market 80,000 shares of BiodesixSEC Form 427 January 2026Common Stock · traded 23 January 2026 · filed 27 January 2026
- ▲ bought on the open market 20,000 shares of BiodesixSEC Form 427 January 2026Common Stock · traded 26 January 2026 · filed 27 January 2026
- ▲ bought on the open market 80,000 shares of BiodesixSEC Form 427 January 2026Common Stock · traded 23 January 2026 · filed 27 January 2026
- ▲ bought on the open market 20,000 shares of BiodesixSEC Form 427 January 2026Common Stock · traded 26 January 2026 · filed 27 January 2026
- ▲ bought on the open market 82,465 shares of BiodesixSEC Form 426 January 2026Common Stock · traded 22 January 2026 · filed 26 January 2026
- ▲ bought on the open market 82,465 shares of BiodesixSEC Form 426 January 2026Common Stock · traded 22 January 2026 · filed 26 January 2026
- ▲ bought on the open market 142,045 shares of BiodesixSEC Form 423 September 2025Common Stock · traded 19 September 2025 · filed 23 September 2025
- ▲ bought on the open market 15,317 shares of BiodesixSEC Form 419 September 2025Common Stock · traded 17 September 2025 · filed 19 September 2025
- ▲ bought on the open market 3,056 shares of BiodesixSEC Form 419 September 2025Common Stock · traded 18 September 2025 · filed 19 September 2025
- ▲ bought on the open market 3,488,372 shares of BiodesixSEC Form 43 September 2025Common Stock · traded 29 August 2025 · filed 3 September 2025
- ▲ bought on the open market 4,000,000 shares of BiodesixSEC Form 420 May 2025Common Stock · traded 16 May 2025 · filed 20 May 2025
- ▲ bought on the open market 723,239 shares of BiodesixSEC Form 420 May 2025Common Stock · traded 19 May 2025 · filed 20 May 2025
- ▲ bought on the open market an unstated number of shares of Aspira Women's Health (a derivative holding)SEC Form 410 March 2025Senior Secured Convertible Note due 2030 · traded 6 March 2025 · filed 10 March 2025
- ▲ bought on the open market 100,000 shares of BiodesixSEC Form 422 November 2024Common Stock · traded 21 November 2024 · filed 22 November 2024
- ▲ bought on the open market 200,000 shares of BiodesixSEC Form 421 November 2024Common Stock · traded 20 November 2024 · filed 21 November 2024
- ▲ bought on the open market 100,253 shares of BiodesixSEC Form 46 November 2024Common Stock · traded 5 November 2024 · filed 6 November 2024
- ▲ bought on the open market 6,536 shares of Aspira Women's Health (a derivative holding)SEC Form 411 July 2024Warrant (Right to Buy) · traded 9 July 2024 · filed 11 July 2024
- ▲ bought on the open market 6,536 shares of Aspira Women's HealthSEC Form 411 July 2024Common Stock · traded 9 July 2024 · filed 11 July 2024
- ▲ bought on the open market 28,500 shares of Aspira Women's Health (a derivative holding)SEC Form 418 June 2024Warrant (Right to Buy) · traded 26 January 2024 · filed 18 June 2024
- ▲ bought on the open market 28,500 shares of Aspira Women's HealthSEC Form 418 June 2024Common Stock · traded 26 January 2024 · filed 18 June 2024
- was granted 46,686 shares of Biodesix (a derivative holding)SEC Form 423 May 2024Restricted Stock Units · traded 21 May 2024 · filed 23 May 2024
- was granted 37,050 shares of Biodesix (a derivative holding)SEC Form 423 May 2024Stock Options (Right to Buy) · traded 21 May 2024 · filed 23 May 2024
- exercised options over 2,174 shares of Biodesix (a derivative holding)SEC Form 423 May 2024Series A Non-Voting Convertible Preferred Stock · traded 23 May 2024 · filed 23 May 2024
- exercised options over 86,960 shares of BiodesixSEC Form 423 May 2024Common Stock · traded 23 May 2024 · filed 23 May 2024
- was granted 1,560,694 shares of Accelerate Diagnostics (a derivative holding)SEC Form 422 May 2024Common Stock Warrants (right to buy) · traded 20 May 2024 · filed 22 May 2024
- was granted 66,667 shares of Accelerate Diagnostics (a derivative holding)SEC Form 421 May 2024Restricted Stock Units · traded 20 May 2024 · filed 21 May 2024
- ▼ sold on the open market 36,000 shares of Yield10 BioscienceSEC Form 417 May 2024Common Stock · traded 20 December 2023 · filed 17 May 2024
- was granted 2,174 shares of Biodesix (a derivative holding)SEC Form 49 April 2024Series A Non-Voting Convertible Preferred Stock · traded 5 April 2024 · filed 9 April 2024
- was granted 1,156,069 shares of Accelerate Diagnostics (a derivative holding)SEC Form 425 January 2024Common Stock Warrants (right to buy) · traded 23 January 2024 · filed 25 January 2024
- was granted 1,156,069 shares of Accelerate DiagnosticsSEC Form 425 January 2024Common Stock · traded 23 January 2024 · filed 25 January 2024
- was granted 105,389 shares of Biodesix (a derivative holding)SEC Form 43 January 2024Restricted Stock Units · traded 1 January 2024 · filed 3 January 2024
- ▼ sold on the open market 36,000 shares of Yield10 BioscienceSEC Form 420 December 2023Common Stock · traded 19 December 2023 · filed 20 December 2023
- ▼ sold on the open market 35,000 shares of Yield10 BioscienceSEC Form 411 December 2023Common Stock · traded 8 December 2023 · filed 11 December 2023
- ▲ bought on the open market 765,000 shares of Yield10 Bioscience (a derivative holding)SEC Form 410 October 2023Common Stock Warrants · traded 15 August 2023 · filed 10 October 2023
- ▲ bought on the open market 765,000 shares of Yield10 BioscienceSEC Form 410 October 2023Common Stock · traded 15 August 2023 · filed 10 October 2023
- ▼ sold on the open market 41,399 shares of Yield10 BioscienceSEC Form 46 October 2023Common Stock · traded 4 October 2023 · filed 6 October 2023
- ▼ sold on the open market 10,670 shares of Yield10 BioscienceSEC Form 46 October 2023Common Stock · traded 5 October 2023 · filed 6 October 2023
- ▼ sold on the open market 37,931 shares of Yield10 BioscienceSEC Form 46 October 2023Common Stock · traded 6 October 2023 · filed 6 October 2023
- ▲ bought on the open market 32,556 shares of BiodesixSEC Form 423 August 2023Common Stock · traded 21 August 2023 · filed 23 August 2023
- ▲ bought on the open market 8,307 shares of BiodesixSEC Form 423 August 2023Common Stock · traded 22 August 2023 · filed 23 August 2023
- ▲ bought on the open market 87,500 shares of BiodesixSEC Form 423 August 2023Common Stock · traded 23 August 2023 · filed 23 August 2023
- was granted 9,989,506 shares of BiodesixSEC Form 411 August 2023Common Stock · traded 3 August 2023 · filed 11 August 2023
- ▲ bought on the open market 181,800 shares of Aspira Women's HealthSEC Form 425 July 2023Common Stock, par value $0.001 · traded 24 July 2023 · filed 25 July 2023
- was granted 4,878,048 shares of Accelerate DiagnosticsSEC Form 420 June 2023Common Stock · traded 9 June 2023 · filed 20 June 2023
- was granted 34,321,163 shares of Accelerate DiagnosticsSEC Form 420 June 2023Common Stock · traded 9 June 2023 · filed 20 June 2023
- returned to the issuer 2,471,710 shares of Accelerate Diagnostics (a derivative holding)SEC Form 416 August 20222.50% Convertible Senior Notes due 2023 · traded 15 August 2022 · filed 16 August 2022
- was granted an unstated number of shares of Accelerate Diagnostics (a derivative holding)SEC Form 416 August 2022Warrants (right to buy) · traded 15 August 2022 · filed 16 August 2022
- ▲ bought on the open market an unstated number of shares of Accelerate Diagnostics (a derivative holding)SEC Form 410 August 20222.50% Convertible Senior Notes due 2023 · traded 9 August 2022 · filed 10 August 2022
- ▲ bought on the open market an unstated number of shares of Accelerate Diagnostics (a derivative holding)SEC Form 49 August 20222.50% Convertible Senior Notes due 2023 · traded 5 August 2022 · filed 9 August 2022
- ▲ bought on the open market an unstated number of shares of Accelerate Diagnostics (a derivative holding)SEC Form 422 June 20222.50% Convertible Senior Notes due 2023 · traded 17 June 2022 · filed 22 June 2022
- ▲ bought on the open market 4,000,000 shares of Soleno Therapeutics (a derivative holding)SEC Form 44 April 2022Warrant (right to buy) · traded 31 March 2022 · filed 4 April 2022
- ▼ sold on the open market 19,748 shares of Soleno TherapeuticsSEC Form 44 April 2022Common Stock · traded 27 July 2021 · filed 4 April 2022
- ▼ sold on the open market 49,841 shares of Soleno TherapeuticsSEC Form 44 April 2022Common Stock · traded 17 August 2021 · filed 4 April 2022
- ▼ sold on the open market 2,599 shares of Soleno TherapeuticsSEC Form 44 April 2022Common Stock · traded 22 September 2021 · filed 4 April 2022
- ▼ sold on the open market 100,000 shares of Soleno TherapeuticsSEC Form 44 April 2022Common Stock · traded 23 September 2021 · filed 4 April 2022
- ▼ sold on the open market 800 shares of Soleno TherapeuticsSEC Form 44 April 2022Common Stock · traded 10 February 2022 · filed 4 April 2022
- ▲ bought on the open market 4,000,000 shares of Soleno TherapeuticsSEC Form 44 April 2022Common Stock · traded 31 March 2022 · filed 4 April 2022
- ▲ bought on the open market 2,298,850 shares of BiodesixSEC Form 431 January 2022Common Stock · traded 30 December 2021 · filed 31 January 2022
- ▼ sold on the open market 65,782 shares of Soleno TherapeuticsSEC Form 43 August 2021Common Stock · traded 7 December 2020 · filed 3 August 2021
- ▼ sold on the open market 63,746 shares of Soleno TherapeuticsSEC Form 43 August 2021Common Stock · traded 8 December 2020 · filed 3 August 2021
- ▼ sold on the open market 33,697 shares of Soleno TherapeuticsSEC Form 43 August 2021Common Stock · traded 30 December 2020 · filed 3 August 2021
- ▼ sold on the open market 520 shares of Soleno TherapeuticsSEC Form 43 August 2021Common Stock · traded 31 December 2020 · filed 3 August 2021
- ▼ sold on the open market 98,862 shares of Soleno TherapeuticsSEC Form 43 August 2021Common Stock · traded 31 December 2020 · filed 3 August 2021
- ▼ sold on the open market 102,000 shares of Soleno TherapeuticsSEC Form 43 August 2021Common Stock · traded 4 January 2021 · filed 3 August 2021
- ▼ sold on the open market 29,723 shares of Soleno TherapeuticsSEC Form 43 August 2021Common Stock · traded 19 January 2021 · filed 3 August 2021
- ▼ sold on the open market 20,277 shares of Soleno TherapeuticsSEC Form 43 August 2021Common Stock · traded 20 January 2021 · filed 3 August 2021
- ▼ sold on the open market 15,566 shares of Soleno TherapeuticsSEC Form 43 August 2021Common Stock · traded 21 January 2021 · filed 3 August 2021
- ▼ sold on the open market 72,591 shares of Soleno TherapeuticsSEC Form 43 August 2021Common Stock · traded 22 January 2021 · filed 3 August 2021
- ▼ sold on the open market 12,818 shares of Soleno TherapeuticsSEC Form 43 August 2021Common Stock · traded 25 January 2021 · filed 3 August 2021
- ▼ sold on the open market 12,763 shares of Soleno TherapeuticsSEC Form 43 August 2021Common Stock · traded 26 January 2021 · filed 3 August 2021
- ▼ sold on the open market 100 shares of Soleno TherapeuticsSEC Form 43 August 2021Common Stock · traded 27 January 2021 · filed 3 August 2021
- ▼ sold on the open market 258,300 shares of Soleno TherapeuticsSEC Form 43 August 2021Common Stock · traded 18 February 2021 · filed 3 August 2021
- ▼ sold on the open market 200 shares of Soleno TherapeuticsSEC Form 43 August 2021Common Stock · traded 25 February 2021 · filed 3 August 2021
- ▼ sold on the open market 248,636 shares of Soleno TherapeuticsSEC Form 43 August 2021Common Stock · traded 8 April 2021 · filed 3 August 2021
- ▼ sold on the open market 250,000 shares of Soleno TherapeuticsSEC Form 43 August 2021Common Stock · traded 9 April 2021 · filed 3 August 2021
- ▼ sold on the open market 80,498 shares of Soleno TherapeuticsSEC Form 43 August 2021Common Stock · traded 28 April 2021 · filed 3 August 2021
- ▼ sold on the open market 5,625 shares of Soleno TherapeuticsSEC Form 43 August 2021Common Stock · traded 30 April 2021 · filed 3 August 2021
- ▼ sold on the open market 248,115 shares of Soleno TherapeuticsSEC Form 43 August 2021Common Stock · traded 5 May 2021 · filed 3 August 2021
- ▼ sold on the open market 41,195 shares of Soleno TherapeuticsSEC Form 43 August 2021Common Stock · traded 18 May 2021 · filed 3 August 2021
- ▼ sold on the open market 35,231 shares of Soleno TherapeuticsSEC Form 43 August 2021Common Stock · traded 15 January 2021 · filed 3 August 2021
- ▼ sold on the open market 14,700 shares of Soleno TherapeuticsSEC Form 43 August 2021Common Stock · traded 3 February 2021 · filed 3 August 2021
- ▼ sold on the open market 700 shares of Soleno TherapeuticsSEC Form 43 August 2021Common Stock · traded 22 February 2021 · filed 3 August 2021
- ▼ sold on the open market 172,717 shares of Soleno TherapeuticsSEC Form 43 August 2021Common Stock · traded 4 March 2021 · filed 3 August 2021
- ▼ sold on the open market 187,985 shares of Soleno TherapeuticsSEC Form 43 August 2021Common Stock · traded 5 March 2021 · filed 3 August 2021
- was granted 34,385 shares of Biodesix (a derivative holding)SEC Form 41 July 2021Stock Options (Right to buy) · traded 29 June 2021 · filed 1 July 2021
- was granted 35,168 shares of Accelerate Diagnostics (a derivative holding)SEC Form 424 May 2021Stock Option (right to buy) · traded 20 May 2021 · filed 24 May 2021
- ▲ bought on the open market 101,400 shares of Yield10 BioscienceSEC Form 44 February 2021Common Stock · traded 3 February 2021 · filed 4 February 2021
- exercised options over 35,157 shares of Biodesix (a derivative holding)SEC Form 49 December 2020Stock Options (Right to Buy) · traded 7 December 2020 · filed 9 December 2020
- exercised options over 23,440 shares of Biodesix (a derivative holding)SEC Form 49 December 2020Stock Options (Right to Buy) · traded 7 December 2020 · filed 9 December 2020
- exercised options over 35,157 shares of BiodesixSEC Form 49 December 2020Common Stock · traded 7 December 2020 · filed 9 December 2020
- exercised options over 23,440 shares of BiodesixSEC Form 49 December 2020Common Stock · traded 7 December 2020 · filed 9 December 2020
- ▲ bought on the open market 365,241 shares of Yield10 BioscienceSEC Form 431 August 2020Common Stock · traded 26 August 2020 · filed 31 August 2020
- ▲ bought on the open market 2,285,715 shares of Aspira Women's HealthSEC Form 46 July 2020Common Stock, par value $0.001 · traded 1 July 2020 · filed 6 July 2020
- ▲ bought on the open market 111,407 shares of Soleno TherapeuticsSEC Form 426 June 2020Common Stock · traded 21 March 2019 · filed 26 June 2020
- ▲ bought on the open market 147,645 shares of Soleno TherapeuticsSEC Form 426 June 2020Common Stock · traded 22 March 2019 · filed 26 June 2020
- ▲ bought on the open market 30,014 shares of Soleno TherapeuticsSEC Form 426 June 2020Common Stock · traded 25 March 2019 · filed 26 June 2020
- ▲ bought on the open market 42,745 shares of Soleno TherapeuticsSEC Form 426 June 2020Common Stock · traded 26 March 2019 · filed 26 June 2020
- ▲ bought on the open market 100,000 shares of Soleno TherapeuticsSEC Form 426 June 2020Common Stock · traded 27 March 2019 · filed 26 June 2020
- ▲ bought on the open market 8,970 shares of Soleno TherapeuticsSEC Form 426 June 2020Common Stock · traded 28 March 2019 · filed 26 June 2020
- ▲ bought on the open market 11,243 shares of Soleno TherapeuticsSEC Form 426 June 2020Common Stock · traded 29 March 2019 · filed 26 June 2020
- ▲ bought on the open market 146,230 shares of Soleno TherapeuticsSEC Form 426 June 2020Common Stock · traded 1 April 2019 · filed 26 June 2020
- ▲ bought on the open market 5,000 shares of Soleno TherapeuticsSEC Form 426 June 2020Common Stock · traded 2 April 2019 · filed 26 June 2020
- ▲ bought on the open market 10,000 shares of Soleno TherapeuticsSEC Form 426 June 2020Common Stock · traded 3 April 2019 · filed 26 June 2020
- ▲ bought on the open market 30,000 shares of Soleno TherapeuticsSEC Form 426 June 2020Common Stock · traded 4 April 2019 · filed 26 June 2020
- ▲ bought on the open market 47,293 shares of Soleno TherapeuticsSEC Form 426 June 2020Common Stock · traded 5 April 2019 · filed 26 June 2020
- ▲ bought on the open market 2,100 shares of Soleno TherapeuticsSEC Form 426 June 2020Common Stock · traded 8 April 2019 · filed 26 June 2020
- ▲ bought on the open market 6,000 shares of Soleno TherapeuticsSEC Form 426 June 2020Common Stock · traded 12 April 2019 · filed 26 June 2020
- ▲ bought on the open market 21,953 shares of Soleno TherapeuticsSEC Form 426 June 2020Common Stock · traded 15 April 2019 · filed 26 June 2020
- ▲ bought on the open market 10,562 shares of Soleno TherapeuticsSEC Form 426 June 2020Common Stock · traded 16 April 2019 · filed 26 June 2020
- ▲ bought on the open market 20,769 shares of Soleno TherapeuticsSEC Form 426 June 2020Common Stock · traded 17 April 2019 · filed 26 June 2020
- ▲ bought on the open market 4,548 shares of Soleno TherapeuticsSEC Form 426 June 2020Common Stock · traded 18 April 2019 · filed 26 June 2020
- ▲ bought on the open market 10,818 shares of Soleno TherapeuticsSEC Form 426 June 2020Common Stock · traded 22 April 2019 · filed 26 June 2020
- ▲ bought on the open market 5,000 shares of Soleno TherapeuticsSEC Form 426 June 2020Common Stock · traded 23 April 2019 · filed 26 June 2020
- ▲ bought on the open market 1,200 shares of Soleno TherapeuticsSEC Form 426 June 2020Common Stock · traded 25 April 2019 · filed 26 June 2020
- ▲ bought on the open market 8,448 shares of Soleno TherapeuticsSEC Form 426 June 2020Common Stock · traded 26 April 2019 · filed 26 June 2020
- ▲ bought on the open market 200 shares of Soleno TherapeuticsSEC Form 426 June 2020Common Stock · traded 1 May 2019 · filed 26 June 2020
- ▲ bought on the open market 800 shares of Soleno TherapeuticsSEC Form 426 June 2020Common Stock · traded 2 May 2019 · filed 26 June 2020
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.